Please assess the completion status of the following clinical trial:

Trial Title: Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Treatment with infliximab for fistulizing CD.~* Administration of at least one infliximab infusion \>=12 months before the chart review.~* 18 years of age or over (men and women).~Exclusion Criteria:~* Subjects not followed for a full year after their first infusion of infliximab.~* Subjects not followed for a full year prior to their first infusion of infliximab.~* Subjects who had participated in clinical studies during the data collection timeframe.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Infliximab (Type: None): Because of the difficulty of finding subjects with exactly the same disease severity, information will be recorded for the time period for up to three years before and for one year after their initial infliximab infusion for comparison of health care costs and utilization prior to infliximab and post infliximab use.

Based on this trial design, predict the completion outcome and termination type (if applicable).